NCT02112916-D2
Dataset Information
Dataset ID: NCT02112916-D2
PubMed ID (PMID):
Publication Title:
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma
Description of Dataset:
NCT02112916-D2: There are two data submissions for PMID 35271306. This dataset, NCT02112916-D2, provides specific incidence of adverse events in interest, as presented in Supplemental Table 15 “Toxicity Comparison AALL1231 vs AALL0434” . It includes patients enrolled on COG study AALL1231 and AALL0434 who experienced targeted grade 3+ adverse events. The data cutoff is 09/30/2021.
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
| NCT Trial Number | Disease Type |
|---|---|
| NCT02112916 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®